Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,209 articlesRevolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
The U.S. signals broader military targets in Iran as tensions flare, sending oil higher and putting pressure on house...
Oil prices stabilize near $72.36 per barrel on July 6, 2026, as markets weigh supply discipline and demand signals. H...
A nationwide rise in foreclosure starts 19% signals mounting pressure in select counties. This guide breaks down wher...
Tesla shares rise on stronger robotaxi momentum and robust delivery data, sparking a broader EV rally as Rivian, Luci...
A top OpenAI robotics executive has resigned amid concerns over guardrails for a Pentagon AI deal. The move signals t...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
Palantir stock down this year has rattled investors. This guide breaks down the fundamentals, what the pullback means...
A fresh inflation read is shifting how Social Security COLAs may grow next year. Analysts say the inflation report re...
Small-cap stocks have staged a surprising comeback as the market navigates a higher-for-longer rate environment. Inve...
A newly released transcript sheds light on how an autopsy doctor hesitated before ruling a death, offering surprising...